• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

When Statin Guidelines Collide: 5 Questions on 2 Approaches to Primary CVD Prevention


Guidelines on primary ASCVD prevention from the USPSTF and the AHA/ACC/Multisociety differ on why and when to initiate a statin. Try the 5-question quiz.

Clinical guidelines on the primary prevention of atherosclerotic cardiovascular disease (ASCVD) from the United States Preventative Services Taskforce (USPSTF; 2022)1 and the American Heart Association/American College of Cardiology/Multisociety ( AHA/ACC/MS; 2018),2 are 2 of the leading resources for evidence-based recommendations on how to mitigate risk of a first CVD event. They differ, however, in the risk factors that suggest and level of risk at which a statin should be initiated.

The following 5 questions test what you know about the differences and the benefit-risk balance of statin therapy.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.